Skip to main content

Advertisement

Log in

Radioguided occult lesion localization in patients with recurrent thyroid cancer

  • Head & Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

Well planned re-surgery is critical for recurrent/persistent thyroid cancer (TC). We aimed to investigate the clinical outcome of radioguided-occult lesion localization (ROLL) guided surgery in patients with recurrent/persistent TC.

Methods

This study includes 29 patients [F/M: 22/7, median age 43 ± 12 years (18–58)] with a diagnosis of TC (22 papillary, 2 follicular and 5 medullary). Before surgery, all patients underwent ultrasonography (USG) guided mapping and intra-lesional radioactivity injection. Surgery was performed based on the excision of radioactivity injected lesions by a gamma probe and non-injected tumor foci via USG-neck map. Researchers determined surgical success by post-operative tumor markers and neck-USG.

Results

Among 29 patients, 60 metastatic lesions were identified by USG [median size 10 ± 6.3 mm (range 5–30)]. Neck-USG performed after surgery provided no evidence of disease (NED) in %97 (28/29) of TC patients. In the follow-up, stimulated thyroglobulin (Tg) levels were less than 1 ng/ml in 79%(19/24) of DTC patients and suppressed Tg < 0.2 ng/ml was noted in 92% (22/24).In patients with DTC with an incomplete structural response, we dramatically changed the American Thyroid Association (ATA) response category and achieved an excellent response in 92% (22/24) of patients. Among patients with MTC, 5/5 patients had normal USG and calcitonin levels were reduced by 60–80% in 4/5 and > 80% in1/5 patients.

Conclusions

In this study we have shown that, ROLL-guided surgery yielded NED rate of %97 (28/29) and increased excellent response rates according to ATA guidelines. Further studies with larger patient groups and longer follow-up should be performed to confirm the efficacy of this surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214

    Article  Google Scholar 

  2. Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86(4):1447–1463

    Article  CAS  PubMed  Google Scholar 

  3. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48(1):6–29

    Article  CAS  PubMed  Google Scholar 

  4. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428

    Article  CAS  PubMed  Google Scholar 

  5. Shen WT, Ogawa L, Ruan D, Suh I, Kebebew E, Duh QY et al (2010) Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 145(3):272–275

    Article  PubMed  Google Scholar 

  6. Pai SI, Tufano RP (2010) Reoperation for recurrent/persistent well-differentiated thyroid cancer. Otolaryngol Clin North Am 43(2):353–363

    Article  PubMed  Google Scholar 

  7. Onkendi EO, McKenzie TJ, Richards ML, Farley DR, Thompson GB, Kasperbauer JL et al (2014) Reoperative experience with papillary thyroid cancer. World J Surg 38(3):645–652

    Article  PubMed  Google Scholar 

  8. Shaha AR, Jaffe BM (1998) Parathyroid preservation during thyroid surgery. Am J Otolaryngol 19(2):113–117

    Article  CAS  PubMed  Google Scholar 

  9. Levin KE, Clark AH, Duh QY, Demeure M, Siperstein AE, Clark OH (1992) Reoperative thyroid surgery. Surgery 111(6):604–609

    CAS  PubMed  Google Scholar 

  10. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M et al (1993) Surgical reintervention for differentiated thyroid cancer. Br J Surg 80(8):1009–1012

    Article  CAS  PubMed  Google Scholar 

  11. Tisell LE, Hansson G, Jansson S, Salander H (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99(1):60–66

    CAS  PubMed  Google Scholar 

  12. Triponez F, Poder L, Zarnegar R, Goldstein R, Roayaie K, Feldstein V et al (2006) Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease. J Clin Endocrinol Metab 91(12):4943–4947

    Article  CAS  PubMed  Google Scholar 

  13. Rubello D, Salvatori M, Pelizzo MR, Rampin L, Fanti S, Gregianin M et al (2006) Radio-guided surgery of differentiated thyroid cancer using (131)I or 99mTc-Sestamibi. Nucl Med Commun 27(1):1–4

    Article  PubMed  Google Scholar 

  14. Ilgan S, Ozturk E, Yildiz R, Emer O, Ayan A, Gorgulu S et al (2010) Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations. Clin Nucl Med 35(11):847–852

    Article  PubMed  Google Scholar 

  15. American Thyroid Association Surgery Working G, American Association of Endocrine S, American Academy of O-H, Neck S, American H, Neck S et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19(11):1153–1158

    Article  Google Scholar 

  16. Stack BC Jr, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S et al (2012) American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22(5):501–508

    Article  PubMed  Google Scholar 

  17. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133

    Article  PubMed  PubMed Central  Google Scholar 

  18. McCoy KL, Yim JH, Tublin ME, Burmeister LA, Ogilvie JB, Carty SE (2007) Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer. Surgery 142(6):965–972

    Article  PubMed  Google Scholar 

  19. Grant CS (2015) Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg 4(1):52–62

    PubMed  PubMed Central  Google Scholar 

  20. Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A et al (2015) Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid 25(1):15–27

    Article  PubMed  Google Scholar 

  21. Hughes DT, Laird AM, Miller BS, Gauger PG, Doherty GM (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957

    Article  PubMed  Google Scholar 

  22. Harari A, Sippel RS, Goldstein R, Aziz S, Shen W, Gosnell J et al (2012) Successful localization of recurrent thyroid cancer in reoperative neck surgery using ultrasound-guided methylene blue dye injection. J Am Coll Surg 215(4):555–561

    Article  PubMed  Google Scholar 

  23. Rubello D, Salvatori M, Ardito G, Mariani G, Al-Nahhas A, Gross MD et al (2007) Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature. Biomed Pharmacother 61(8):477–481

    Article  CAS  PubMed  Google Scholar 

  24. Giles YS, Sarici IS, Tunca F, Sormaz IC, Salmaslioglu A, Adalet I et al (2014) The rate of operative success achieved with radioguided occult lesion localization and intraoperative ultrasonography in patients with recurrent papillary thyroid cancer. Surgery 156(5):1116–1126

    Article  PubMed  Google Scholar 

  25. Bellotti C, Castagnola G, Tierno SM, Centanini F, Sparagna A, Vetrone I et al (2013) Radioguided surgery with combined use of gamma probe and hand-held gamma camera for treatment of papillary thyroid cancer locoregional recurrences: a preliminary study. Eur Rev Med Pharmacol Sci 17(24):3362–3366

    CAS  PubMed  Google Scholar 

  26. Lee L, Steward DL (2008) Sonographically-directed neck dissection for recurrent thyroid carcinoma. Laryngoscope 118(6):991–994

    Article  PubMed  Google Scholar 

  27. Gulcelik MA, Karaman N, Dogan L, Sahiner I, Akgul GG, Kahraman YS et al (2017) Radioguided occult lesion localization for locally recurrent thyroid carcinoma. Eur Arch Otorhinolaryngol 274(7):2915–2919

    Article  PubMed  Google Scholar 

  28. Rondeau G, Fish S, Hann LE, Fagin JA, Tuttle RM (2011) Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid 21(8):845–853

    Article  PubMed  PubMed Central  Google Scholar 

  29. Garbaccio V, Menga M, Mensa G, Passera R, Galati A, Codegone A et al (2017) Impact of radioguided occult lesion localization (ROLL) in the management of cervical recurrences from differentiated thyroid cancer. Q J Nucl Med Mol Imaging. https://doi.org/10.23736/S1824-4785.17.03027-8

    Article  PubMed  Google Scholar 

  30. Rowland KJ, Jin LX, Moley JF (2015) Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis. Ann Surg Oncol 22(1):96–102

    Article  PubMed  Google Scholar 

  31. Lee HS, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY et al (2015) Risk factors for re-recurrence after first reoperative surgery for locoregional recurrent/persistent papillary thyroid carcinoma. World J Surg 39(8):1943–1950

    Article  PubMed  Google Scholar 

  32. Cayonu M, Acar A, Eryilmaz A, Oguz O (2014) Surgical approach and outcomes for revision surgery of the central neck compartment. J Craniofac Surg 25(5):1797–1800

    Article  PubMed  Google Scholar 

Download references

Funding

This study received no funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Murat Tuncel.

Ethics declarations

Conflict of ınterest

Authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional Ethical Committee at the University-Hospital Hacettepe approved this study (Approval number: GO 15/561-05).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuncel, M., Süslü, N. Radioguided occult lesion localization in patients with recurrent thyroid cancer. Eur Arch Otorhinolaryngol 276, 1757–1766 (2019). https://doi.org/10.1007/s00405-019-05377-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-019-05377-w

Keywords

Navigation